11-71435785-C-T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2
The NM_001360.3(DHCR7):c.1018G>A(p.Val340Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000398 in 1,608,398 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V340V) has been classified as Likely benign.
Frequency
Consequence
NM_001360.3 missense
Scores
Clinical Significance
Conservation
Publications
- Smith-Lemli-Opitz syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001360.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DHCR7 | NM_001360.3 | MANE Select | c.1018G>A | p.Val340Ile | missense | Exon 9 of 9 | NP_001351.2 | ||
| DHCR7 | NM_001425107.1 | c.1069G>A | p.Val357Ile | missense | Exon 10 of 10 | NP_001412036.1 | |||
| DHCR7 | NM_001425108.1 | c.1054G>A | p.Val352Ile | missense | Exon 9 of 9 | NP_001412037.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DHCR7 | ENST00000355527.8 | TSL:1 MANE Select | c.1018G>A | p.Val340Ile | missense | Exon 9 of 9 | ENSP00000347717.4 | ||
| DHCR7 | ENST00000407721.6 | TSL:1 | c.1018G>A | p.Val340Ile | missense | Exon 9 of 9 | ENSP00000384739.2 | ||
| DHCR7 | ENST00000685320.1 | c.433G>A | p.Val145Ile | missense | Exon 8 of 8 | ENSP00000509319.1 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152234Hom.: 0 Cov.: 35 show subpopulations
GnomAD2 exomes AF: 0.000958 AC: 236AN: 246260 AF XY: 0.00104 show subpopulations
GnomAD4 exome AF: 0.000366 AC: 533AN: 1456164Hom.: 3 Cov.: 37 AF XY: 0.000386 AC XY: 279AN XY: 723478 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000703 AC: 107AN: 152234Hom.: 0 Cov.: 35 AF XY: 0.00113 AC XY: 84AN XY: 74376 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Smith-Lemli-Opitz syndrome Uncertain:1Benign:1
Inborn genetic diseases Uncertain:1
The p.V340I variant (also known as c.1018G>A), located in coding exon 7 of the DHCR7 gene, results from a G to A substitution at nucleotide position 1018. The valine at codon 340 is replaced by isoleucine, an amino acid with highly similar properties. This variant was previously reported in the SNPDatabase as rs148081697. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.01% (1/12982) total alleles studied, having been observed in 0.02% (1/4396) African American alleles. This amino acid position is not well conserved in available vertebrate species, and isoleucine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at